Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002;4 Suppl 3(Suppl 3):S51-61.
doi: 10.1186/ar573. Epub 2002 May 9.

Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics

Affiliations
Review

Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics

Hideaki Nagase et al. Arthritis Res. 2002.

Abstract

Matrix metalloproteinases (MMPs) play a central role in many biological processes such as development, morphogenesis and wound healing, but their unbalanced activities are implicated in numerous disease processes such as arthritis, cancer metastasis, atherosclerosis, nephritis and fibrosis. One of the key mechanisms to control MMP activities is inhibition by endogenous inhibitors called tissue inhibitors of metalloproteinases (TIMPs). This review highlights the structures and inhibition mechanism of TIMPs, the biological activities of TIMPs, the unique properties of TIMP-3, and the altered specificity towards MMPs achieved by mutagenesis. A potential therapeutic use of TIMP variants is discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A ribbon diagram of tissue inhibitor of metalloproteinases 1 (TIMP-1) bound to the catalytic domain of matrix metalloproteinase 3 [MMP-3 (ΔC)]. TIMP-1 is shown in green and MMP-3 (ΔC) is shown in light brown. Cystines, Thr2, Val4 and Ser68 in TIMP-1 are indicated: N, blue; O, red; C, grey; and disulfide bonds, yellow. Strands and helices in TIMP-1 are labelled A–J and 1–4, respectively. The catalytic and structural zinc ions are shown in purple, and calcium ions are shown in orange. The image was prepared from the Brookhaven Protein Data Bank entry (1UEA) using the Swiss PDB viewer [91].
Figure 2
Figure 2
A schematic display of the secondary structure of tissue inhibitor of metalloproteinases 1 (TIMP-1). The crystal structure of TIMP-1 was determined as a complex with the catalytic domain of MMP-3 [86]. Strands (A–J) and helices (H1–H4) are shown. Two glycosylation sites are indicated by diamonds.
Figure 3
Figure 3
A schematic representation of (a) the N-terminal region of tissue inhibitor of metalloproteinases 1 (TIMP-1) and (b) a peptidyl-hydroxamate inhibitor. The scheme of TIMP-1 is based on the crystal structure of the TIMP-1-MMP-3(ΔC) complex [86].
Figure 4
Figure 4
The surface structure of tissue inhibitor of metalloproteinases 1 (TIMP-1). The N-terminal domain and the C-terminal domain are shown in light red and green, respectively. The region within 4 Å contact with the matrix metalloproteinase (MMP) catalytic domain is shown in blue. Mutation sites coloured red modulate the selectivity of N-TIMP-1 against different MMPs. The image was prepared from the Brookhaven Protein Data Bank entry (1UEA) using the Swiss PDB viewer [91].

Similar articles

Cited by

References

    1. Poole AR, Mort JS, Roughley PJ. In: In Joint Cartilage Degradation: Basic and Clinical Aspects. Edited by Woessner JF Jr, Howell DS., editor. New York: Marcel Dekker;; 1993. Methods for evaluating mechanisms of cartilage breakdown. pp. 225–260.
    1. Caterson B, Flannery CR, Hughes GE, Little CB. Mechanisms involved in cartilage proteoglycan catabolism. Matrix Biol. 2000;19:333–344. doi: 10.1016/S0945-053X(00)00078-0. - DOI - PubMed
    1. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem. 1999;274:21491–21494. doi: 10.1074/jbc.274.31.21491. - DOI - PubMed
    1. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463–516. doi: 10.1146/annurev.cellbio.17.1.463. - DOI - PMC - PubMed
    1. Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, Kinne RW, Santavirta S, Sorsa T, López-Otín C, Takagi M. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis. 1999;58:691–697. - PMC - PubMed

Publication types

MeSH terms

Substances